Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Update

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) was the target of a significant increase in short interest in November. As of November 15th, there was short interest totalling 2,890,000 shares, an increase of 15.6% from the October 31st total of 2,500,000 shares. Currently, 8.1% of the shares of the stock are sold short. Based […]

Related Keywords

France ,China ,United States ,Montreal ,Quebec ,Canada ,Los Angeles ,California ,America ,Richardk Prins ,Piper Sandler ,Williamj Peters ,Los Angeles Capital Management ,Amphastar Pharmaceuticals Stock ,News Ratings For Amphastar Pharmaceuticals Daily ,Envestnet Asset Management Inc ,Amphastar Pharmaceuticals Inc ,Nasdaq ,Insider Activity At Amphastar Pharmaceuticals ,Securities Exchange Commission ,Tudor Investment Corp Et Al ,Amphastar Pharmaceuticals ,Guidance Capital Inc ,Get Free Report ,Director Richard ,Exchange Commission ,Angeles Capital Management ,Montreal Can ,Asset Management ,Finished Pharmaceutical Products ,Active Pharmaceutical Ingredient ,Amphastar Pharmaceuticals Daily ,Nasdaq Amph ,Amph ,Medical ,Stocks ,Options ,Put ,Call ,